Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Targeted therapy
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05118789
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ROS-1
Systemic Treatment-Naive
Chemotherapy
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Kidney cancer
#NCT05096390
Other
Locally Advanced
Metastatic
Systemic Treatment-Naive
Systemic Treatment-Naive
Centre Antoine Lacassagne (Nice), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), IUCT Oncopôle (Toulouse), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy) (and 2 more...)
Centre Léon Bérard
Phase 2
Breast cancer
#NCT04985266
HER2 Negative
HR Positive
Localized
Surgery
Chemotherapy
Hormone therapy
Targeted therapy
Institut de Cancérologie et d’Hématologie Universitaire de Saint-Étienne (CHU Saint-Étienne) (Saint-Priest-en-Jarez), Institut Bergonié (Bordeaux), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Hospitalier Annecy Genevois (Epagny Metz-Tessy), Centre Hospitalier de Blois (Blois) (and 16 more...)
Fiducie de la Fondation Royal Marsden NHS
Phase 2
Colon cancer
Rectal cancer
#NCT04730544
Locally Advanced
Metastatic
MSI/dMMR
MSS
Immunotherapy
Bispecific T-cell engager antibodies
Immunotherapy
Bispecific T-cell engager antibodies
Institut Sainte Catherine (Avignon), CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Hospitalier Universitaire de Lille (Lille) (and 9 more...)
GERCOR - Groupe Coopératif Multidisciplinaire d'Oncologie
Phase 2
Lymphoma
#NCT04446962
B cell lymphoma
Primary cerebral lymphoma
Systemic Treatment-Naive
None
Centre Hospitalier Universitaire de Besançon (Besançon), Centre Hospitalier Universitaire de Clermont Ferrand (Clermont-Ferrand), Centre Antoine Lacassagne (Nice), Centre Henri Becquerel (Rouen ), Centre Hospitalier de Colmar (Colmar) (and 17 more...)
Institut Curie
Phase 2
Kidney cancer
#NCT04299646
Clear cell carcinoma
Metastatic
Systemic Treatment-Naive
Immunotherapy
Targeted therapy
0
1 or 2
Centre François Baclesse (Caen ), Institut de Cancérologie de Bourgogne - Site de Dijon (Dijon), Gustave Roussy (Villejuif), Centre Oscar Lambret (Lille)
Centre François Baclesse
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04268121
Neuroendocrine tumor
Localized
CHU - Haut-lévêque - Bordeaux (Pessac), Centre Hospitalier Universitaire de Poitiers - Site de la Milétrie (Poitiers), Centre Hospitalier Universitaire de Toulouse (Toulouse), CHU Amiens-Picardie (site sud) (Amiens), Centre Hospitalier Universitaire de Besançon (Besançon) (and 4 more...)
Phase 2
Breast cancer
#NCT04143711
HER2 Low
HER2 Positive
Locally Advanced
Metastatic
Targeted therapy
Antibody Drug Conjugates (ADC)
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics
Phase 2
Breast cancer
#NCT04143711
HER2 Negative
HR Positive
Locally Advanced
Metastatic
Systemic Treatment-Naive
Groupe Hospitalier Saint André (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Institut Paoli-Calmettes (Marseille), Institut Curie - Paris (Paris) (and 2 more...)
Dragonfly Therapeutics